Skip to main content

Fluoxetine Before Colorectal Cancer Surgery

Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer

  • RegistryNCT06225011
  • PhasePhase 1
  • StatusRecruiting
  • ConditionColorectal Adenocarcinoma Planning Surgery
  • SponsorJonsson Comprehensive Cancer Center
How Fluoxetine worksNCT062250111 min

What the film says

Read the transcript

This trial is for adults with colorectal cancer who are planning surgery.

The idea: give fluoxetine, also known as Prozac, by mouth before the operation. Fluoxetine is a selective serotonin reuptake inhibitor commonly used for depression and anxiety. Researchers want to see whether it changes immune cells in the tumor before surgery.

This phase 1 study plans 10 patients. At UCLA's Jonsson Comprehensive Cancer Center in Los Angeles, Jasmine Mitchell leads it.

Public record; not medical advice.

Sources behind this film

  • ClinicalTrials.gov record NCT06225011

    Adults; colorectal cancer before surgery; Fluoxetine (Prozac) by mouth before surgery; Whether it changes immune cells in the tumor; Phase 1; 10 patients (+1 more lines)

The drug

What is being tested.

PRIMARY OBJECTIVE: I. To evaluate alterations in tumor immune cell composition and activity under SSRI treatment. OUTLINE: Patients receive fluoxetine orally (PO) once daily (QD) for 10 days prior to surgery.

The study

How the trial runs.

This phase I trial tests whether fluoxetine (prozac) works to modify the tumor immune cells before surgery in patients with colorectal cancer. Fluoxetine is a commonly used selective serotonin reuptake inhibitor (SSRI) prescribed for major depressive disorder and generalized anxiety.

Giving fluoxetine may modify the immune cell composition in the tumor and its microenvironment and may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread in patients with colorectal cancer.

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • Male or female ≥ 18 years of age at visit 1
  • Previously untreated cytologically or histologically confirmed colorectal adenocarcinoma that will not need neoadjuvant therapy
  • Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study
  • World Health Organization (WHO) Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • Absolute neutrophil count (ANC) ≥ 1.5x10^9/L
  • Platelets ≥ 100x10^9/L

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.